Gotowe bibliografie tematyczne / Alzheimer's disease – Diagnosis

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Alzheimer's disease – Diagnosis”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 20 lutego 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Alzheimer's disease – Diagnosis”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Alzheimer's disease – Diagnosis"

1

Sianturi, Aditya Gloria Monalisa. "Stadium, Diagnosis, dan Tatalaksana Penyakit Alzheimer." Majalah Kesehatan Indonesia 2, no. 2 (October 25, 2021): 39–44. http://dx.doi.org/10.47679/makein.202132.

Pełny tekst źródła
Streszczenie:
Dementia is a general term for loss of memory that can occur along with behavioral or psychological symptoms in patients. The first cause of dementia patients is Alzheimer's disease. Alzheimer’s disease is a brain degenerative disease and the most common cause of dementia. In Alzheimer’s disease, there are three development stages, which is stage 1, stage 2, and stage 3 with different clinical symptoms at each stage. There are several clinical criteria for establishing a definitive diagnosis of Alzheimer’s disease and also support examinations have to be carried out. Until now, Alzheimer’s tre
Style APA, Harvard, Vancouver, ISO itp.
2

Dinsmore, Steven T. "Alzheimer's disease diagnosis." Journal of the American Osteopathic Association 99, no. 9_suppl (September 1, 1999): S1. http://dx.doi.org/10.7556/jaoa.1999.99.9.s1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Zarrouk, Amira, Meryam Debbabi, Maryem Bezine, El Mostafa Karym, Asmaa Badreddine, Olivier Rouaud, Thibault Moreau, et al. "Lipid Biomarkers in Alzheimer's Disease." Current Alzheimer Research 15, no. 4 (February 22, 2018): 303–12. http://dx.doi.org/10.2174/1567205014666170505101426.

Pełny tekst źródła
Streszczenie:
Background: There are now significant evidences that lipid metabolism is affected in numerous neurodegenerative diseases including Alzheimer’s disease. These dysfunctions lead to abnormal levels of certain lipids in the brain, cerebrospinal fluid and plasma. It is consequently of interest to establish lipid profiles in neurodegenerative diseases. This approach, which can contribute to identify lipid biomarkers of Alzheimers' disease, can also permit to identify new therapeutic targets. It was therefore of interest to focus on central and peripheral biomarkers in Alzheimer's disease. Methods: A
Style APA, Harvard, Vancouver, ISO itp.
4

Ashford, J. Wesson, Frederick A. Schmitt, and Vinod Kumar. "Diagnosis of Alzheimer's Disease." Psychiatric Annals 26, no. 5 (May 1, 1996): 262–68. http://dx.doi.org/10.3928/0048-5713-19960501-06.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Reisberg, Barry, and Alistair Burns. "Diagnosis of Alzheimer's Disease." International Psychogeriatrics 9, S1 (December 1997): 5–7. http://dx.doi.org/10.1017/s1041610297004651.

Pełny tekst źródła
Streszczenie:
This issue on the diagnosis of Alzheimer's disease (AD) is the product of a special meeting of the International Psychogeriatric Association with the cosponsorship of Alzheimer's Disease International, the European Federation of Neurological Societies, the World Health Organization, and the World Psychiatric Association. The meeting was held in Geneva, Switzerland, from November 10 to 12, 1996. Participants included many of the leading experts on the various aspects of AD diagnosis as well as clinical experts, general experts in the field of AD, organizational representatives, and outstanding
Style APA, Harvard, Vancouver, ISO itp.
6

Lindley, R. I., and M. S. Dennis. "Diagnosis of Alzheimer's disease." BMJ 302, no. 6767 (January 5, 1991): 47. http://dx.doi.org/10.1136/bmj.302.6767.47-b.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Manning, F. C. "Diagnosis of Alzheimer's disease." BMJ 302, no. 6767 (January 5, 1991): 47–48. http://dx.doi.org/10.1136/bmj.302.6767.47-c.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Byrne, E. J. "Diagnosis of Alzheimer's disease." BMJ 302, no. 6767 (January 5, 1991): 48. http://dx.doi.org/10.1136/bmj.302.6767.48.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Tozer, R. "Diagnosis of Alzheimer's disease." BMJ 302, no. 6767 (January 5, 1991): 48. http://dx.doi.org/10.1136/bmj.302.6767.48-a.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Wald, N., C. Parkes, and A. D. Smith. "Diagnosis of Alzheimer's disease." BMJ 302, no. 6771 (February 2, 1991): 292. http://dx.doi.org/10.1136/bmj.302.6771.292-b.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Alzheimer's disease – Diagnosis"

1

Wang, Xueli. "Organic molecules for diagnosis and therapy of Alzheimer's disease." HKBU Institutional Repository, 2020. https://repository.hkbu.edu.hk/etd_oa/883.

Pełny tekst źródła
Streszczenie:
Alzheimer's disease has become one of the most common diseases jeopardizing the health of the human being. The main pathological feature of AD is the accumulation of Aβ in the brain to form senile plaques. Therefore, it is of great significance to develop new and efficient drugs targeting at amyloid-β for the detection, diagnosis and therapeutics for Alzheimer's disease. Xanthohumol (Xn) naturally presents in hops (Humulus lupulus L). Studies have shown that it has anti-lipoperoxidative, anti-inflammatory, anti-proliferative activities, antiangiogenic and antioxidant effects, which further ill
Style APA, Harvard, Vancouver, ISO itp.
2

Andreasen, Niels. "Search for reliable diagnostic markers for Alzheimer's disease /." Stockholm, 2000. http://diss.kib.ki.se/2000/91-628-4039-8/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Haigh, Anne-Marie Francoise. "The Alzheimer's Disease Life Events Study." Thesis, Oxford Brookes University, 2009. http://radar.brookes.ac.uk/radar/items/9c1acdb7-0df9-4046-ec50-810f9122e1d0/1.

Pełny tekst źródła
Streszczenie:
The Alzheimer's Disease Life Events study examines whether there is a relationship between life events and Alzheimer's disease (AD). The ADLE study uses a mixed methods approach to answer the central research question:Are life events a risk factor for Alzheimer's disease? The central research question uses the following theory questions to examine:1. Is there a difference between the number of life events between patients and controls, using the Life Events and Difficulties Schedule (LEDS)(Brown and Harris, 1978) as a measurement tool?2. Is there a difference in the way (i.e. positive, neutral
Style APA, Harvard, Vancouver, ISO itp.
4

Bogdanovic, Nenad. "Alzheimer's disease : towards a multifaceted approach in neuropathological diagnosis /." Stockholm, 1998. http://diss.kib.ki.se/1998/91-628-2846-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Sayeed, Abdul. "Positron emission tomography analysis of Alzheimer's disease." Thesis, University of Surrey, 2001. http://epubs.surrey.ac.uk/842834/.

Pełny tekst źródła
Streszczenie:
Alzheimer's Disease (AD) is a major concern for the elderly population, currently affecting over 670,000 people in the UK. With the continual increase in the age of the population the problem is expected to rise. There is no known cure to the condition and a definite diagnosis cannot be made in life. Clinical diagnosis is considered to be approximately 80% - 90% accurate, sometimes taking up to a year to assess. Early detection could aid in the care and possible development of better treatments or even a cure. AD has been shown to alter the structure and global texture of the brain. Studies us
Style APA, Harvard, Vancouver, ISO itp.
6

Casson, Roland James. "Making sense of a diagnosis of Alzheimer's disease : partners' experiences." Thesis, University of Hertfordshire, 2004. http://hdl.handle.net/2299/14242.

Pełny tekst źródła
Streszczenie:
Objectives This study aimed to explore the personal experiences and meanings that people develop in response to their partner being diagnosed with Alzheimer's disease, and how these inform the ways in which they cope with and manage their situation in the early stages. Method In-depth interviews were conducted with four women whose partners had received a diagnosis of early-stage Alzheimer's disease from specialist services within the past six months. Interpretative Phenomenological Analysis was used to identify themes running within their accounts. Results Three key themes emerged from the an
Style APA, Harvard, Vancouver, ISO itp.
7

Gonzalez, Murcia Josue David. "Diagnosis and the Role of Chemokine Receptors in Alzheimer's Disease." BYU ScholarsArchive, 2020. https://scholarsarchive.byu.edu/etd/8888.

Pełny tekst źródła
Streszczenie:
Alzheimer’s disease (AD) is the most common neurodegenerative disorder and is the main cause of dementia in the elderly population. AD is pathologically characterized by the accumulation of amyloid plaques and neurofibrillary tangles that results in neurodegeneration and loss of memory function. However, diagnosis of AD and characterization of biological mechanisms that lead to pathology and modulate risk for disease has proven to be extremely difficult. Cerebrospinal fluid (CSF) contains critical biomarkers for AD such as levels of amyloid beta (Aβ) phosphorylated-tau (p-tau), total-tau (t-ta
Style APA, Harvard, Vancouver, ISO itp.
8

Fedotova, M. S. "Current issues in the diagnosis and treatment of Alzheimer's disease." Thesis, БДМУ, 2021. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18901.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Smith, André P. "Medicalizing intersubjectivity : diagnostic practices and the self in Alzheimer's disease." Thesis, McGill University, 2000. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=36792.

Pełny tekst źródła
Streszczenie:
Alzheimer's disease (AD) is a condition marked by progressive intellectual decline and memory loss, which typically affects individuals over the age of 60. Its origins are unknown but genetic factors are suspected in some cases. There is limited information about the subjective experience of AD although it is often described as a calamity that inevitably destroys the self irrespective of its victims' social circumstances. This dissertation offers an alternative to this nihilistic portrayal that draws on a critical phenomenological framework. It explores the loss of self as an intersubjective p
Style APA, Harvard, Vancouver, ISO itp.
10

Kixmiller, Jeffrey S. "Subtyping patients with Senile Dementia of the Alzheimer type using cluster analysis." Virtual Press, 1992. http://liblink.bsu.edu/uhtbin/catkey/833474.

Pełny tekst źródła
Streszczenie:
The purpose of this study was to determine if distinct subgroups of patients with Senile Dementia of the Alzheimer Type (SDAT) could be identified using seven scales of the Cognitive Behavior Rating Scale (CBRS). Ward's method of cluster analysis was used to group 104 patients with a probable diagnosis of SDAT into subtypes.The following three clusters were identified: (a) Moderately Impaired, (b) Severely Impaired, and (c) Emotionally Intact which displayed differences in symptom severity. Clusters could be partially defined by the amount of time they had been diagnosed with the disease. Diff
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Alzheimer's disease – Diagnosis"

1

Ronson, Charles E. Alzheimer's diagnosis. New York: Nova Science Publishers, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Boyd, Marisa R. Alzheimer's disease diagnosis and treatments. Hauppauge, N.Y: Nova Science, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Juergen, Bludau, ed. Alzheimer's disease. Santa Barbara, Calif: Greenwood, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Scinto, Leonard F. M., and Kirk R. Daffner. Early Diagnosis of Alzheimer's Disease. New Jersey: Humana Press, 2000. http://dx.doi.org/10.1385/1592590055.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

1950-, Gauthier Serge, ed. Clinical diagnosis and management of Alzheimer's disease. 2nd ed. London: Martin Dunitz, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Khalid, Iqbal, and International Conference on Alzheimer's Disease and Related Disorders (5th : 1996 : Osaka, Japan), eds. Alzheimer's disease: Biology, diagnosis, and therapeutics. Chichester: Wiley, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Alistair, Burns, and Pettit William J, eds. Alzheimer's disease in primary care. London: Martin Dunitz, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Michaelides, Efstathios E. (Stathis). Alzheimer's disease: Methods and protocols. [Place of publication not identified]: Humana, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

E, Becker Robert, and Giacobini Ezio, eds. Alzheimer disease: Current research in early diagnosis. New York: Taylor & Francis, 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Daniela, Galimberti, and Scarpani Elio, eds. Biomarkers for early diagnosis of Alzheimer's disease. New York: Nova Science, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Alzheimer's disease – Diagnosis"

1

Nagaraj, Siranjeevi, Madhu Ramesh, and Thimmaiah Govindaraju. "Chapter 14. Circulating Biomarkers for the Diagnosis of Alzheimer's Disease." In Alzheimer's Disease, 415–41. Cambridge: Royal Society of Chemistry, 2022. http://dx.doi.org/10.1039/9781839162732-00415.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Rajkumar, Gomathi, Murugan Rajan, Mairim Russo Serafini, Narendra Narain, Adriano A. S. Araujo, Lucindo José Quintans Júnior, and Lijing Ke. "Inside Alzheimer's Disease Diagnosis." In Nanophytomedicine, 39–48. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003231745-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Ramesh, Madhu, Sourav Samanta, and Thimmaiah Govindaraju. "Chapter 13. Molecular Probes for the Diagnosis of Alzheimer's Disease with Implications for Multiplexed and Multimodal Strategies." In Alzheimer's Disease, 377–414. Cambridge: Royal Society of Chemistry, 2022. http://dx.doi.org/10.1039/9781839162732-00377.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Menéndez González, Manuel. "Differential Diagnosis." In Atlas of Biomarkers for Alzheimer's Disease, 17–21. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-07989-9_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Estrada, Lisbell D., and Claudio Soto. "Strategies for Alzheimer's Disease Diagnosis." In Current Hypotheses and Research Milestones in Alzheimer's Disease, 217–26. Boston, MA: Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-87995-6_18.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Richly, Pablo, Facundo Manes, and Julián Bustin. "Depression and Alzheimer's Disease." In Depression in Neurologic Disorders: Diagnosis and Management, 177–88. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118348093.ch14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Gauthier, Serge. "Update on Alzheimer's Disease Diagnosis and Management." In The Care of the Older Person, 20–23. 5th ed. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003344476-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Menéndez González, Manuel. "Early Diagnosis and Risk of Conversion from Presymptomatic Stages." In Atlas of Biomarkers for Alzheimer's Disease, 1–15. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-07989-9_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Arai, Tetsuaki. "Diagnostic Criteria for Alzheimer’s Disease." In Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias, 11–19. Tokyo: Springer Japan, 2017. http://dx.doi.org/10.1007/978-4-431-55133-1_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Matsuda, Hiroshi, and Etsuko Imabayashi. "Structural Neuroimaging in Alzheimer’s Disease." In Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias, 21–38. Tokyo: Springer Japan, 2017. http://dx.doi.org/10.1007/978-4-431-55133-1_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Alzheimer's disease – Diagnosis"

1

Senna, Priscylla de, Wyllians Borelli, Wagner Brum, Eduardo Zimmer, Márcia Chaves, Arthur Schuh, and Raphael Castilhos. "FUNCTIONAL COGNITIVE DISORDER AS THE MOST FREQUENT DIAGNOSIS IN PUBLIC MEMORY CLINIC." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda059.

Pełny tekst źródła
Streszczenie:
Background: Functional cognitive disorder (FCD) has been described as a blind spot of dementia care. Objectives: Identify the frequency of FCD in a tertiary memory clinic (TMC). Methods: A retrospective analysis was conducted to identify new referrals from the primary care setting to a TMC from southern Brazil over 2014 to 2020. Diagnostic protocol included neurologic evaluation, cognitive screening, neuroimaging and laboratory testing. FCD was defined as cognitive complaints without objective cognitive decline, in the absence of evidence of neurodegenerative disease. Data is shown in mean (SD
Style APA, Harvard, Vancouver, ISO itp.
2

Jiao, Jianling, Timon C. Liu, Yan Li, and Songhao Liu. "Early neuroimaging diagnosis of Alzheimer's disease." In International Workshop on Photonics and Imaging in Biology and Medicine, edited by Qingming Luo, Britton Chance, and Valery V. Tuchin. SPIE, 2002. http://dx.doi.org/10.1117/12.462540.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Amira, Ben Rabeh, Benzarti Faouzi, Amiri Hamid, and Mouna Bouaziz. "Computer-assisted diagnosis of Alzheimer's disease." In 2014 First International Image Processing, Applications and Systems Conference (IPAS). IEEE, 2014. http://dx.doi.org/10.1109/ipas.2014.7043281.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Morgado, Pedro, Margarida Silveira, and Durval Campos Costa. "Texton-based diagnosis of Alzheimer's disease." In 2013 IEEE International Workshop on Machine Learning for Signal Processing (MLSP). IEEE, 2013. http://dx.doi.org/10.1109/mlsp.2013.6661913.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Ramos, Júlia Xavier, Bruno Zacarias, Breno Barbosa, and Simone Brandão. "18-FDG PET ANALYSYS FOR DEMENTIA DIAGNOSIS- BASELINE RESULTS FROM A REFERENCE CENTER IN RECIFE, BRAZIL." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda061.

Pełny tekst źródła
Streszczenie:
Background: Positrons emission tomography associated with computed tomography- PET/CT using the 18 F-fluorodeoxyglucose is a well-established exam for the medical evaluation of dementia, mainly helping in differential diagnosis to determine the specific type of dementia. Objectives: To describe the role of the PET/CT in the differential diagnosis of dementia in patients. Methods: a single-center, descriptive and records-based analysis of patients with Dementia evaluated in a clinic of Neurology at Recife and referred to PET/ CT due to diagnosis uncertainty, between 2020-2021. Results: 29 patie
Style APA, Harvard, Vancouver, ISO itp.
6

Santos, Roberto, and Rita Fernandes. "THE ACCURACY OF TRANSCRANIAL SONOGRAPHY ON ALZHEIMER’S DISEASE DIAGNOSIS." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda044.

Pełny tekst źródła
Streszczenie:
Background: The diagnosis of Alzheimer’s disease (AD) is clinical, combining neurological examination, neuropsychological tests and neuroimaging. One of the anatomical features of AD is medial temporal lobe (MTL) atrophy graduated by magnetic resonance imaging (MRI) with accuracy to discriminate between healthy controls, mild neurocognitive disorder (MCI) or dementia, but it has its limitations. Transcranial sonography (TCS) demonstrated good accuracy to display changes in echogenicity or size of intracranial structures. Objective: The objective of this study is to evaluate TCS diagnostic accu
Style APA, Harvard, Vancouver, ISO itp.
7

Zawawi, Nour, Heba Gamal Saber, Mohamed Hashem, and Tarek F.Gharib. "Predicting Alzheimer's Disease Progression by Combining Multiple Measures." In 2nd International Conference on NLP Techniques and Applications (NLPTA 2021). Academy and Industry Research Collaboration Center (AIRCC), 2021. http://dx.doi.org/10.5121/csit.2021.111913.

Pełny tekst źródła
Streszczenie:
Alzheimer's disease (AD) is a degenerative brain ailment that affects millions worldwide. It is the most common form of dementia. Patients with an early diagnosis of Alzheimer's disease have a strong chance of preventing additional brain damage by halting nerve cell death. At the same time, it begins to progress several years before any symptoms appear. The variety of data is the biggest problem encountered during diagnosis. Neurological examination, brain imaging, and often asked questions from his connected closed relatives are the three forms of data that a neurologist or geriatrics employs
Style APA, Harvard, Vancouver, ISO itp.
8

Sahumbaiev, Ivan, Anton Popov, Nataliia Ivanushkina, Javier Ramirez, and Juan Manuel Gorriz. "Florbetapir Image Analysis for Alzheimer's Disease Diagnosis." In 2018 IEEE 38th International Conference on Electronics and Nanotechnology (ELNANO). IEEE, 2018. http://dx.doi.org/10.1109/elnano.2018.8477516.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Lodha, Priyanka, Ajay Talele, and Kishori Degaonkar. "Diagnosis of Alzheimer's Disease Using Machine Learning." In 2018 Fourth International Conference on Computing Communication Control and Automation (ICCUBEA). IEEE, 2018. http://dx.doi.org/10.1109/iccubea.2018.8697386.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Vovk, Alla, Ameera Patel, and Dennis Chan. "Augmented Reality for Early Alzheimer's Disease Diagnosis." In CHI '19: CHI Conference on Human Factors in Computing Systems. New York, NY, USA: ACM, 2019. http://dx.doi.org/10.1145/3290607.3313007.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Alzheimer's disease – Diagnosis"

1

Rostaminejad, Marzieh. Early Diagnosis of Alzheimer's disease using Electrochemical-based Nanobiosensors for miRNA Detection. Peeref, July 2022. http://dx.doi.org/10.54985/peeref.2207p6024343.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Zuo, Lingyan, Fengting Zhu, Rui Wang, Hongyan Shuai, and Xin Yu. Music intervention affects the quality of life on Alzheimer’s disease: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2021. http://dx.doi.org/10.37766/inplasy2021.12.0055.

Pełny tekst źródła
Streszczenie:
Review question / Objective: Inclusion criteria: population: 1) A randomized controlled study on the impact of music intervention on the QOL of patients with AD; 2) The participants in this study is patients with AD; 3) There is no significant difference among age, gender and education background in sorted groups before analysis which make these groups comparable; intervention: 1)Intervention Modality Music-based intervention; comparison: 1) All data were sorted into two groups: the music intervention group and the control group without any music intervention; outcome: 1) The indicators evalua
Style APA, Harvard, Vancouver, ISO itp.
3

Ma, Yunxing, Julia Brettschneider, and Joanna Collingwood. A systematic review and meta-analysis of cerebrospinal fluid amyloid and tau levels in patients progressing from Mild Cognitive Impairment to Alzheimer’s Disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2022. http://dx.doi.org/10.37766/inplasy2022.7.0020.

Pełny tekst źródła
Streszczenie:
Review question / Objective: Reported levels of amyloid-beta and tau in human cerebrospinal fluid (CSF) are evaluated to discover if these biochemical markers can predict the transition from Mild Cognitive Impairment (MCI) to Alzheimer’s disease (AD). A systematic review and quantitative meta-analyses are performed to test relationships between three potential biomarkers in CSF (Aβ(1-42), T-tau, and P-tau181) and the evolution of AD in longitudinal evaluations of levels relative to baseline, using prior-published experimental data. The primary focus of the analysis is on the period describing
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Alzheimer's disease – Diagnosis” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii